Billionaire Larry Robbins' Top Healthcare Picks for Q2
Larry Robbins' Glenview Capital has been underperforming the broader market and the overall hedge fund industry for over a year now.
Abbvie Inc. (ABBV)
Market is closed
News
- First
- << Previous
- 401 - 410
- Next >>
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros.
Why These 5 Stocks Are Trending Today
The markets are trading in the red today after investor sentiment was dented following the Labor Department's assertion that the U.S economy inched up by 0.5% in the first quarter, below expectations...
Tipp Hill Cashes Out of Gold Stocks, Puts It Into Healthcare
Syracuse University graduate Richard L. Haydon named his fund after the Tipperary Hill area, his childhood neighborhood. Before establishing Tipp Hill Capital Management in 2009, Mr.
Toronto-based Breton Hill Added These 5 Stocks to its Portfolio in Q1
Toronto-based Breton Hill Capital recently submitted its 13F filing with the SEC for the reporting period of March 31, revealing a U.S equity portfolio worth $271.7 million.
Why Are Investors Excited About These 5 Stocks Today?
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China's slowdown.
Stocks Financial Advisors Are Interested In: Costco, Facebook & More
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central banks.
Do Hedge Funds Love AbbVie Inc (ABBV)?
After years of low interest rates, retail investors continue to starve for income while awaiting higher yields.
Five Dividend Aristocrats Hedge Funds Are Bullish On
Amid the latest market volatility, dividend investing is one of the safest bets on the equity markets.
AbbVie Inc (ABBV): A Cheap Dividend Aristocrat Yielding Over 4%
AbbVie Inc (NYSE:ABBV) is one of the more controversial dividend aristocrats for several reasons.
- First
- << Previous
- 401 - 410
- Next >>
Billionaire Hedge Funds
